Results 91 to 100 of about 2,002 (144)

Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial [PDF]

open access: yesJournal of Allergy and Clinical Immunology, 2018
van Anrooij, Bjorn   +6 more
openaire   +1 more source

Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis

open access: yesHaematologica, 2011
Luis Escribano   +5 more
doaj   +1 more source

Symptom patterns before and after indolent systemic mastocytosis: A matched cohort analysis. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Tse KY   +13 more
europepmc   +1 more source

Assessing real-world natural history of indolent systemic mastocytosis: A retrospective matched cohort study. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Pongdee T   +10 more
europepmc   +1 more source

IgE-mediated anaphylaxis to methylprednisolone succinate in a patient with indolent systemic mastocytosis

open access: yesAllergology International, 2022
Eugénie Van Mieghem   +5 more
doaj   +1 more source

Cardiac Bypass Surgery in a Patient with an Indolent Systemic Mastocytosis [PDF]

open access: yesJournal of Anesthesia & Intensive Care Medicine, 2018
Beckers, Stefan   +7 more
openaire   +3 more sources

SYSTEMIC MASTOCYTOSIS: CURRENT PROGRESS AND CHALLENGES

open access: yesHaematologica
Mastocytosis refers to a group of rare disorders caused by the expansion and accumulation of clonal mast cells in various organs and tissues.1 Two main entities can be distinguished: cutaneous forms, typically occurring in childhood, and systemic forms ...
I. Tanasi
doaj  

Home - About - Disclaimer - Privacy